載入...
CSPG4 as Target for CAR-T-Cell Therapy of Various Tumor Entities–Merits and Challenges
Targeting cancer cells using chimeric-antigen-receptor (CAR-)T cells has propelled adoptive T-cell therapy (ATT) to the next level. A plentitude of durable complete responses using CD19-specific CAR-T cells in patients suffering from various lymphoid malignancies resulted in the approval by the food...
Na minha lista:
| 發表在: | Int J Mol Sci |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
MDPI
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6928974/ https://ncbi.nlm.nih.gov/pubmed/31779130 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20235942 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|